![](/develop/static/imgs/pdf.png)
Efficacy and safety of JAK inhibitor INC424 in patients with primary and post-polycythemia vera or post-essential thrombocythemia myelofibrosis in the Chinese population
{{custom_author.name}}, {{article.zuoZheEn}}
Efficacy and safety of JAK inhibitor INC424 in patients with primary and post-polycythemia vera or post-essential thrombocythemia myelofibrosis in the Chinese population
[{{custom_ref.label}}] |
{{custom_citation.content}}
CrossRef
ADS
Pubmed
arXiv
Google scholar
|
/
〈 |
|
〉 |